(Q37164085)

English

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria

scientific article published on September 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria (English)

1 reference

Europe PubMed Central

18 August 2017

24

object named as

L Joseph Wheat

1 reference

Europe PubMed Central

18 August 2017

Thierry Calandra

object named as

Thierry Calandra

13

0 references

Raoul Herbrecht

object named as

Raoul Herbrecht

2

0 references

10

object named as

John R Perfect

1 reference

Europe PubMed Central

18 August 2017

Lindsey R Baden

16

object named as

Lindsey R Baden

1 reference

Europe PubMed Central

18 August 2017

Dimitrios P Kontoyiannis

19

object named as

Dimitrios P Kontoyiannis

1 reference

Europe PubMed Central

18 August 2017

7

object named as

Thomas J Walsh

1 reference

Europe PubMed Central

18 August 2017

Peter G. Pappas

17

object named as

Peter G Pappas

1 reference

Europe PubMed Central

18 August 2017

8

object named as

Johan Maertens

1 reference

Europe PubMed Central

18 August 2017

5

object named as

Jack Sobel

1 reference

Europe PubMed Central

18 August 2017

Thomas F Patterson

9

object named as

Thomas F Patterson

1 reference

Europe PubMed Central

18 August 2017

Luis L Ostrosky-Zeichner

4

object named as

Luis Ostrosky-Zeichner

1 reference

Europe PubMed Central

18 August 2017

30

object named as

Ben E De Pauw

1 reference

Europe PubMed Central

18 August 2017

1

object named as

Brahm H Segal

1 reference

Europe PubMed Central

18 August 2017

Claudio Viscoli

6

object named as

Claudio Viscoli

1 reference

Europe PubMed Central

18 August 2017

12

object named as

John R Wingard

1 reference

Europe PubMed Central

18 August 2017

Bertrand Dupont

11

object named as

Bertrand Dupont

1 reference

Europe PubMed Central

18 August 2017

Maria Anna Viviani

21

object named as

Maria Anna Viviani

1 reference

Europe PubMed Central

18 August 2017

Nikolaos G Almyroudis

23

object named as

Nikolaos G Almyroudis

1 reference

Europe PubMed Central

18 August 2017

26

object named as

Eric J Bow

1 reference

Europe PubMed Central

18 August 2017

Bart Jan Kullberg

28

object named as

Bart-Jan Kullberg

1 reference

Europe PubMed Central

18 August 2017

author name string

David A Stevens

3

1 reference

Europe PubMed Central

18 August 2017

Carol A Kauffman

14

1 reference

Europe PubMed Central

18 August 2017

John R Graybill

15

1 reference

Europe PubMed Central

18 August 2017

John E Bennett

18

1 reference

Europe PubMed Central

18 August 2017

Catherine Cordonnier

20

1 reference

Europe PubMed Central

18 August 2017

Jacques Bille

22

1 reference

Europe PubMed Central

18 August 2017

Wolfgang Graninger

25

1 reference

Europe PubMed Central

18 August 2017

Steven M Holland

27

1 reference

Europe PubMed Central

18 August 2017

William E Dismukes

29

1 reference

Europe PubMed Central

18 August 2017

language of work or name

0 references

publication date

1 September 2008

1 reference

Europe PubMed Central

18 August 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

Clinical Infectious Diseases

1 reference

Europe PubMed Central

18 August 2017

47

1 reference

Europe PubMed Central

18 August 2017

5

1 reference

Europe PubMed Central

18 August 2017

674-683

1 reference

Europe PubMed Central

18 August 2017

Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

When primary antifungal therapy fails

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Changes in causes of death over time after treatment for invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Immune reconstitution syndrome associated with opportunistic mycoses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Pretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

A drug-sensitive genetic network masks fungi from the immune system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Detection of Circulating Aspergillus fumigatus Galactomannan: Value and Limits of the Platelia Test for Diagnosing Invasive Aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Forum report: issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groups.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Dexamethasone in adults with bacterial meningitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Anticryptococcal effect of amphotericin B is mediated through macrophage production of nitric oxide.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukaemia in haematological complete remission. A retrospective study and review of the literature. Gimema Infection Program (Gruppo Italiano

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Itraconazole therapy for chronic coccidioidal meningitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

6 September 2017

Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

14 September 2017

Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

14 September 2017

Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

14 September 2017

Randomized trial of four vs. seven days of ceftriaxone treatment for bacterial meningitis in children with rapid initial recovery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

14 September 2017

Amphotericin B-induced interleukin-1beta expression in human monocytic cells is calcium and calmodulin dependent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

14 September 2017

Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

14 September 2017

Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

14 September 2017

Miconazole in the Treatment of Coccidioidomycosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

14 September 2017

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

27 June 2018

Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

27 June 2018

Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

27 June 2018

Itraconazole treatment of coccidioidomycosis. NAIAD Mycoses Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

27 June 2018

The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

27 June 2018

Learning from our failures: the antifungal treatment conundrum.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

3 September 2018

The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

3 September 2018

A scheme for defining cause of death and its application in the T cell depletion trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

3 September 2018

Issues related to the design and interpretation of clinical trials of salvage therapy for invasive mold infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

3 September 2018

Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

3 September 2018

The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

3 September 2018

Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

3 September 2018

Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

3 September 2018

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

3 September 2018

Combination therapy for invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

3 September 2018

Combination antifungal therapy for invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

3 September 2018

Cyclophosphamide metabolism is affected by azole antifungals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

3 September 2018

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

3 September 2018

Comparison of caspofungin and amphotericin B for invasive candidiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

3 September 2018

Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

3 September 2018

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

3 September 2018

Aspergillus antigen in serum, urine and bronchoalveolar lavage specimens of neutropenic patients in relation to clinical outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

3 September 2018

Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

3 September 2018

Is it ever safe to stop azole therapy for Coccidioides immitis meningitis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671230

3 September 2018

A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18637757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18637757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France

1 reference

https://pubmed.ncbi.nlm.nih.gov/18637757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18637757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18637757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18637757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infusion-related toxicity of three different amphotericin B formulations and its relation to cytokine plasma levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/18637757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18637757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trial design for mold-active agents: time to break the mold--aspergillosis in neutropenic adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/18637757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/18637757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis: a study of 56 patients with hematologic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18637757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety of Discontinuation of Maintenance Therapy for Disseminated Histoplasmosis after Immunologic Response to Antiretroviral Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18637757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance

1 reference

https://pubmed.ncbi.nlm.nih.gov/18637757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18637757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis. Influence of bone marrow recovery in patients with acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18637757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Invasive pulmonary aspergillosis and acute leukemia. Limitations in the diagnostic utility of the air crescent sign

1 reference

https://pubmed.ncbi.nlm.nih.gov/18637757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ketoconazole therapy of progressive coccidioidomycosis. Comparison of 400- and 800-mg doses and observations at higher doses

1 reference

https://pubmed.ncbi.nlm.nih.gov/18637757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CT findings in fungal opportunistic pneumonias: body and brain involvement

1 reference

https://pubmed.ncbi.nlm.nih.gov/18637757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/18637757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluconazole therapy for coccidioidal meningitis. The NIAID-Mycoses Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18637757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37164085&oldid=2125748627"